Public Profile

Pharmascience Inc.

Pharmascience Inc., a leading player in the pharmaceutical industry, is headquartered in California and operates extensively across North America and beyond. Founded in 2003, the company has established itself as a trusted provider of high-quality generic medications and innovative healthcare solutions. Pharmascience's core offerings include a diverse range of prescription and over-the-counter products, distinguished by their commitment to safety, efficacy, and affordability. The company has achieved significant milestones, including numerous regulatory approvals and partnerships that enhance its market presence. With a strong focus on research and development, Pharmascience Inc. continues to advance its product portfolio, positioning itself as a key contributor to the global healthcare landscape. Its dedication to quality and patient care has earned it a reputable standing in the competitive pharmaceutical market.

DitchCarbon Score

How does Pharmascience Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Pharmascience Inc.'s score of 13 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.

91%

Pharmascience Inc.'s reported carbon emissions

Pharmascience Inc., headquartered in CA, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or defined initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the sector increasingly focuses on sustainability, Pharmascience Inc. may need to establish clear climate commitments and reduction strategies to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pharmascience Inc.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Pharmascience Inc. is headquartered in CA, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pharmascience Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Taking Reduction Action?

Similar Organizations

Viatris

US
Chemicals nec
Updated about 1 hour ago

Bausch Health Cos

CA
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Bristol Myers Squibb Canada Co.

CA
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Novartis Pharmaceuticals Canada Inc.

CA
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

GlaxoSmithKline Inc.

CA
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Sandoz Canada Inc.

CA
Chemicals nec
Updated about 1 month ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers